Semaglutide
US$ 23.90
glp 1 agonist in ckd GLP-1 Receptor Agonists and Kidney Protection GLP1 Receptor Agonists vs SGLT2-I
Description
Zhao, H
doi: 10.2337/diab.28.12.1141 [DOI] [PubMed] [Google Scholar] 172
Highlights of 2024: The year the obesity market took shape The market for anti-obesity medications (AOMs) reached a major milestone in 2024 with global spend exceeding $30Bn for the first time, an over ten-fold increase since 2020
Gamble J-M, Chibrikov E, Midodzi WK, Twells LK, Majumdar SR
This section compares the most clinically relevant adverse events across every major option
[DOI] [PubMed] [Google Scholar] 137.Wu Y., Yang Z., Cao Q
